What does Neith Corporation do?

Neith Corporation (6236.TWO) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 6236.TWO's market cap?

Neith Corporation (6236.TWO) has a market capitalization of approximately $726.9 million, as of August 27, 2026, based on the most recent share price and shares outstanding.

Does 6236.TWO pay a dividend?

No — Neith Corporation (6236.TWO) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Is 6236.TWO profitable?

Neith Corporation (6236.TWO) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

6236.TWO

Neith Corporation

TWO·Biotechnology · Healthcare

NT$17.45NT$1.55+9.75%

Market capNT$726.86M·Market closed·Aug 27 4:03 AM UTC

Price Chart

NT$17.45+NT$1.55 (+9.75%)today

+31.20%CAGR +5.59%

Select date range

FromTo

Jun 30, 2005Aug 28, 2021 → Aug 28, 2026· 5.0 yrsAug 28, 2026

Key Metrics

6236.TWO does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report DateDec 31

Reported vs EstimateNT$0.04

Earnings Surprise—

FinancialsFinancials Tab

RevenueNT$31.84M

Net IncomeNT$324.00K

Net Margin1.0%

Operating Cash FlowNT$4.65M

Capital ExpendituresNT$0.00

Free Cash FlowNT$4.65M

Return on Equity0.2%

Return on Invested Capital−0.5%

Net CashNT$133.47M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 6236.TWO and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 6236.TWO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 6236.TWO and 80,000+ other tickers.

About Neith Corporation

Neith Corporation operates in diverse sectors, encompassing biotechnology, medical aesthetics, and preventive health solutions. The company provides a variety of nutritional supplements, including L-One, a liquid formula designed to support ocular well-being, and EPlus, a multi-enzyme blend. Additional nutritional offerings are marketed under the King One brand. Beyond supplements, Neith also offers genetic testing services. Its product portfolio extends to a wide array of wellness and energy-enhancing items, such as versatile mattresses (energy and dual-purpose), energy-infused masks…

CEO: Yuefeng Lin
Sector: Healthcare
Industry: Biotechnology
Exchange: TWO
Employees: 51
Website: www.neithcorp.com

Peers

NeoCore Technology Co., Ltd.

Cap

NT$1.2B

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 6236.TWO

What does Neith Corporation do?: Neith Corporation (6236.TWO) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 6236.TWO's market cap?: Neith Corporation (6236.TWO) has a market capitalization of approximately $726.9 million, as of August 27, 2026, based on the most recent share price and shares outstanding.
Does 6236.TWO pay a dividend?: No — Neith Corporation (6236.TWO) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is 6236.TWO profitable?: Neith Corporation (6236.TWO) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.